Prior authorization request form Form
Please answer all questions to determine coverage (0 of 3)
Biomagnetic Therapy
Proprietary information of EmblemHealth/ConnectiCare. © 2025 EmblemHealth & Affiliates
POLICY NUMBER
LAST REVIEW
MG.MM.ME.59C9
August 8, 2025
Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved.
The treating physician or primary care provider must submit to EmblemHealth the clinical evidence that the member meets the criteria for the
treatment or surgical procedure. Without this documentation and information, EmblemHealth will not be able to properly review the request
preauthorization or post-payment review. The clinical review criteria expressed below reflects how EmblemHealth determines whether certain services
or supplies are medically necessary. This clinical policy is not intended to pre-empt the judgment of the reviewing medical director or dictate to health
care providers how to practice medicine. Health care providers are expected to exercise their medical judgment in rendering appropriate care. Health
care providers are expected to exercise their medical judgment in rendering appropriate care.
EmblemHealth established the clinical review criteria based upon a review of currently available clinical information (including clinical outcome studies
in the peer reviewed published medical literature, regulatory status of the technology, evidence-based guidelines of public health and health research
agencies, evidence-based guidelines and positions of leading national health professional organizations, views of physicians practicing in relevant clinical
areas, and other relevant factors). EmblemHealth expressly reserves the right to revise these conclusions as clinical information changes and welcomes
further relevant information. Each benefit program defines which services are covered. The conclusion that a particular service or supply is medically
necessary does not constitute a representation or warranty that this service or supply is covered and/or paid for by EmblemHealth, as some programs
exclude coverage for services or supplies that EmblemHealth considers medically necessary.
If there is a discrepancy between this guideline and a member's benefits program, the benefits program will govern. Identification of selected brand
names of devices, tests and procedures in a medical coverage policy is for reference only and is not an endorsement of any one device, test or procedure
over another. In addition, coverage may be mandated by applicable legal requirements of a state, the Federal Government or the Centers for Medicare
& Medicaid Services (CMS) for Medicare and Medicaid members. All coding and web site links are accurate at time of publication.
EmblemHealth may also use tools developed by third parties, such as the MCG™ Care Guidelines, to assist us in administering health benefits. The
MCG™ Care Guidelines are intended to be used in connection with the independent professional medical judgment of a qualified health care provider
and do not constitute the practice of medicine or medical advice. EmblemHealth Services Company, LLC, has adopted this policy in providing
management, administrative and other services to EmblemHealth Plan, Inc., EmblemHealth Insurance Company, EmblemHealth Services Company, LLC,
and Health Insurance Plan of Greater New York (HIP) related to health benefit plans offered by these entities. All of the aforementioned entities are
affiliated companies under common control of EmblemHealth Inc.
Definitions
Biomagnetic therapy (aka magnetic therapy, magnetherapy, magnotherapy, static magnetic field therapy or
therapeutic magnets) consists of placing a magnet on or near the skin using a variety of devices (e.g., bracelets,
necklaces, insoles, sleeves, head bands, mattress pads, etc.) to create an electromagnetic field to areas of
musculoskeletal damage or perceived discomfort. Proposed uses include degenerative joint conditions such as
osteoarthritis, joint and tendon injury.
Guideline
Biomagnetic therapy is considered investigational and not medically necessary.
Limitations and Exclusions
Biomagnetic therapy, in any capacity, is not considered medically necessary for pain management (or any
disease/condition) due to insufficient evidence of therapeutic value.
Proprietary information of EmblemHealth/ConnectiCare, Inc. © 2025 EmblemHealth & Affiliates
Page 2 of 2
Procedure Codes
97799
Unlisted physical medicine/rehabilitation service or procedure
References
- Carpenter JS, Wells N, Lambert B, et al. A pilot study of magnet therapy for hot flashes after breast cancer. Cancer Nursing. 2002; 25(2):104-109.
- Cepeda MS, Carr DB, Sarquis T, et al. Static magnetic therapy does not decrease pain or opioid requirements: a randomized double-blind trial. Anesth Analg. 2007; 104(2):290-294.
- Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. Cochrane Database Syst Rev. 2014; (3):CD008797.
- Colbert AP, Markov MS, Carlson N, et al. Static magnetic field therapy for carpal tunnel syndrome: a feasibility study. Arch Phys Med Rehabil. 2010; 91(7):1098-1104.
- Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database of Syst Rev. 2003; (3):CD000416.
- National Center for Complimentary and Integrative Health. Magnets for pain relief. Updated December 2017. Available at: https://nccih.nih.gov/health/magnet/magnetsforpain.htm. Accessed August 15, 2024.
- Pittler MH, Brown, EM, Ernst E. Static magnets for reducing pain: systematic review and meta-analysis of randomized trials. CMAJ. 2007; 177(7):736-742.
- Richmond SJ, Brown SR, Campion PD, et al. Therapeutic effects of magnetic and copper bracelets in osteoarthritis: a randomised placebo-controlled crossover trial. Complement Ther Med. 2009; 17(5-6):249-256.
- Richmond SJ, Gunadasa S, Bland M, Macpherson H. Copper bracelets and magnetic wrist straps for rheumatoid arthritis-analgesic and anti-inflammatory effects: a randomised double-blind placebo-controlled crossover trial. PLoS One. 2013; 8(9):e71529.
- Specialty matched clinical peer review.
- Stones W, Cheong YC, Howard FM. Interventions for treating chronic pelvic pain in women. Cochrane Database of Syst Rev. 2005; (2):CD000387.
- Winemiller MH, Billow RG, Laskowski ER, et al. Effect of magnetic vs. sham-magnetic insoles on plantar heel pain. JAMA. 2003; 290(11):1474-1478.
- Wolsko PM, Eisenberg DM, Simon LS, et al. Double-blind placebo-controlled trial of static magnets for the treatment of osteoarthritis of the knee: results of a pilot study. Alternative Therapies. 2004; 10(2):36-43. Revision History Company(ies) DATE REVISION EmblemHealth Aug. 8, 2025 Transferred policy content to individual company branded template ConnectiCare Dec. 2019 ConnectiCare adopts the clinical criteria of its parent corporation EmblemHealth
Walk through this policy with us
Review how this policy can be converted into cited criteria, prior authorization checks, and operational automation.